Are Bajaj Healthcare Ltd latest results good or bad?
2026-05-09 19:16:48Bajaj Healthcare Ltd's latest financial results for the quarter ended March 2026 present a complex picture. The company reported a net loss of ₹19.41 crores, a significant shift from a profit of ₹11.59 crores in the same quarter last year. This loss was primarily attributed to exceptional charges that overshadowed operational improvements. In terms of revenue, Bajaj Healthcare recorded net sales of ₹153.06 crores, which reflects a slight decline of 0.91% year-on-year and a more pronounced decrease of 5.06% compared to the previous quarter. Despite these challenges, the operating profit margin (excluding other income) showed notable improvement, rising to 14.82% from 7.61% a year earlier, indicating effective cost management and operational efficiency. Looking at the full fiscal year 2026, the company achieved a net sales growth of 14.60%, totaling ₹542.00 crores, and a net profit of ₹42.00 crores, markin...
Read More
Bajaj Healthcare Ltd is Rated Sell by MarketsMOJO
2026-05-09 10:10:36Bajaj Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Bajaj Healthcare Ltd Technical Momentum Shifts Amid Bearish Sentiment
2026-04-29 08:03:27Bajaj Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from mildly bearish to a more pronounced bearish stance. Despite some mildly bullish signals on weekly MACD and KST indicators, the overall technical landscape remains challenging, with key moving averages and monthly indicators signalling caution for investors.
Read More
Bajaj Healthcare Ltd Faces Bearish Momentum Amid Technical Deterioration
2026-04-27 08:02:30Bajaj Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, signalling increased bearishness. The stock’s recent downgrade to a Strong Sell rating by MarketsMOJO, combined with deteriorating technical indicators, underscores mounting challenges for investors amid a volatile market backdrop.
Read MoreBajaj Healthcare Falls 7.02%: 3 Key Factors Driving the Weekly Decline
2026-04-25 13:03:17Key Events This Week 20 Apr: Stock opens at Rs.333.85, down 4.33% on heavy volume 21 Apr: Downgrade to Strong Sell rating announced 22 Apr: Technical indicators signal bearish momentum; stock closes at Rs.329.05 23 Apr: Mild technical recovery but overall bearish sentiment persists 24 Apr: Week closes at Rs.324.45, down 2.48% on the day Week OpenRs.333.85</d...
Read MoreBajaj Healthcare Gains 3.96%: Technical Momentum Shift Amid Mixed Fundamentals
2026-04-18 13:03:16Key Events This Week 13 Apr: Rating upgraded to Sell on technical improvements 13 Apr: Technical momentum shifts to mildly bearish 15 Apr: Sharp price surge of 6.67% amid broader market rally 17 Apr: Week closes at Rs.348.95, up 3.96% for the week Week OpenRs.333.40 Week CloseRs.348.95<di...
Read More
Bajaj Healthcare Ltd Upgraded to Sell on Technical Improvements Despite Lingering Fundamental Concerns
2026-04-13 08:17:20Bajaj Healthcare Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook despite persistent fundamental challenges. The upgrade, effective from 10 April 2026, is driven primarily by an improvement in technical indicators, while valuation and financial trends present a mixed picture for investors navigating the Pharmaceuticals & Biotechnology sector.
Read More
Bajaj Healthcare Ltd Sees Technical Momentum Shift Amid Mixed Market Signals
2026-04-13 08:03:49Bajaj Healthcare Ltd has exhibited a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a nuanced change in investor sentiment. Despite a 3.63% gain on the day, the micro-cap pharmaceutical stock continues to face headwinds from key technical indicators, signalling a cautious approach for investors amid mixed signals from momentum oscillators and moving averages.
Read More
Bajaj Healthcare Ltd is Rated Sell by MarketsMOJO
2026-04-11 10:10:37Bajaj Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 10 April 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 11 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read MoreDisclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011
15-Jun-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Anil Jain
Compliances-Reg.24(A)-Annual Secretarial Compliance
30-May-2026 | Source : BSEAnnual Secretarial Compliance Report
Announcement under Regulation 30 (LODR)-Newspaper Publication
10-May-2026 | Source : BSEIntimation for Newspaper Publication
Corporate Actions
No Upcoming Board Meetings
Bajaj Healthcare Ltd has declared 20% dividend, ex-date: 19 Sep 25
Bajaj Healthcare Ltd has announced 5:10 stock split, ex-date: 28 Sep 21
Bajaj Healthcare Ltd has announced 1:1 bonus issue, ex-date: 09 Apr 19
No Rights history available